CoChat

The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.

A Large Gene Network in Immature Erythroid Cells Is Controlled by the Myeloid and B Cell Transcriptional Regulator PU.1

Open access

Abstract

PU.1 is a hematopoietic transcription factor that is required for the development of myeloid and B cells. PU.1 is also expressed in erythroid progenitors, where it blocks erythroid differentiation by binding to and inhibiting the main erythroid promoting factor, GATA-1. However, other mechanisms by which PU.1 affects the fate of erythroid progenitors have not been thoroughly explored. Here, we used ChIP-Seq analysis for PU.1 and gene expression profiling in erythroid cells to show that PU.1 regulates an extensive network of genes that constitute major pathways for controlling growth and survival of immature erythroid cells. By analyzing fetal liver erythroid progenitors from mice with low PU.1 expression, we also show that the earliest erythroid committed cells are dramatically reduced in vivo. Furthermore, we find that PU.1 also regulates many of the same genes and pathways in other blood cells, leading us to propose that PU.1 is a multifaceted factor with overlapping, as well as distinct, functions in several hematopoietic lineages.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pgen.1001392

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Genome-wide binding of PU.1 is very similar in ES-EP and MEL cells. (A) ChIP-Seq peaks were identified as described in Materials and Methods. A point represents the log2 of the number of sequence reads from ES-EP and MEL cells contained in a peak. Each peak was assigned to one of two categories based on the ratio of the number of reads in the two cell types. Peaks within a ratio ≤5 are classified as shared between both cell types (represented in light blue), whereas peaks with a ratio >5 are enriched in a cell specific manner (represented in red for ES-EP or dark blue for MEL cells). (B) Venn diagrams illustrate the number of peaks (left) or genes with a peak within 2 kb of TSSs (right) in ES-EP and MEL cells (colors as A).
Figure 1 Genome-wide binding of PU.1 is very similar in ES-EP and MEL cells. (A) ChIP-Seq peaks were identified as described in Materials and Methods. A point represents the log2 of the number of sequence reads from ES-EP and MEL cells contained in a peak. Each peak was assigned to one of two categories based on the ratio of the number of reads in the two cell types. Peaks within a ratio ≤5 are classified as shared between both cell types (represented in light blue), whereas peaks with a ratio >5 are enriched in a cell specific manner (represented in red for ES-EP or dark blue for MEL cells). (B) Venn diagrams illustrate the number of peaks (left) or genes with a peak within 2 kb of TSSs (right) in ES-EP and MEL cells (colors as A).CC BY · PubMed Central
Figure 2 Properties of the PU.1 ChIP-Seq peaks in ES-EP and MEL cells. (A) Sample signal tracks of PU.1 ChIP-Seq data from MEL cells and ES-EP are shown for an ∼500 kb region of chromosome 15 in the Integrated Genome Browser (IGB) (Affymetrix), with the y-axis representing the number of reads. Input DNA controls are also shown for both cell types. (B) Sequence logos for the enriched motifs within PU.1 ChIP-Seq peaks from MEL (left) and ES-EP (right) cells, derived from MEME motif analysis (see Materials and Methods). (C) The distance between each PU.1 ChIP-Seq peak and the TSS within 2 kb was computed and the results are binned and plotted for MEL (top left) and ES-EP (bottom left). Peaks were further annotated by their genomic locations with respect to current gene annotation (right) and classified as proximal promoter (+/−2 kb of TSS), 3′ end of gene (+/−2 kb of TES), gene body (between +2 kb of TSS and −2 kb of TES), miRNA promoters, or otherwise intergenic regions.
Figure 2 Properties of the PU.1 ChIP-Seq peaks in ES-EP and MEL cells. (A) Sample signal tracks of PU.1 ChIP-Seq data from MEL cells and ES-EP are shown for an ∼500 kb region of chromosome 15 in the Integrated Genome Browser (IGB) (Affymetrix), with the y-axis representing the number of reads. Input DNA controls are also shown for both cell types. (B) Sequence logos for the enriched motifs within PU.1 ChIP-Seq peaks from MEL (left) and ES-EP (right) cells, derived from MEME motif analysis (see Materials and Methods). (C) The distance between each PU.1 ChIP-Seq peak and the TSS within 2 kb was computed and the results are binned and plotted for MEL (top left) and ES-EP (bottom left). Peaks were further annotated by their genomic locations with respect to current gene annotation (right) and classified as proximal promoter (+/−2 kb of TSS), 3′ end of gene (+/−2 kb of TES), gene body (between +2 kb of TSS and −2 kb of TES), miRNA promoters, or otherwise intergenic regions.CC BY · PubMed Central
Figure 3 PU.1-dependent gene expression in erythroid cells. (A) PU.1 target genes with a 2-fold expression difference (as measured by Affymetrix gene array) between MEL and ES-EP cells were identified. The log2 of the number of PU.1 ChIP-Seq reads within peaks of these genes' promoters are computed and plotted here. Blue circles represent genes for which expression is higher in MEL cells, while red circles represent genes for which expression is higher in ES-EP. The diameter of each circle is proportional to the degree of difference in gene expression between the two cell types. (B) The expression levels of genes with and without PU.1 bound at proximal promoters in MEL and ES-EP are shown as boxplots, with the lower and upper sides of the box representing the lower and upper quartiles, respectively, and the line in the box representing the median expression value. (C) The log2ratio of the fold change in gene expression from early erythroid progenitors derived from wild-type embryos compared with PU.1 low embryos for genes bound by PU.1 in MEL (left) or ES-EP (right) are plotted as a function of the number of reads associated with the peak(s) corresponding to each gene. The positions of the values for Klf1, EpoR, Gfi1b, Myb, Fli1, and Sfpi1 in the plots are labeled.
Figure 3 PU.1-dependent gene expression in erythroid cells. (A) PU.1 target genes with a 2-fold expression difference (as measured by Affymetrix gene array) between MEL and ES-EP cells were identified. The log2 of the number of PU.1 ChIP-Seq reads within peaks of these genes' promoters are computed and plotted here. Blue circles represent genes for which expression is higher in MEL cells, while red circles represent genes for which expression is higher in ES-EP. The diameter of each circle is proportional to the degree of difference in gene expression between the two cell types. (B) The expression levels of genes with and without PU.1 bound at proximal promoters in MEL and ES-EP are shown as boxplots, with the lower and upper sides of the box representing the lower and upper quartiles, respectively, and the line in the box representing the median expression value. (C) The log2ratio of the fold change in gene expression from early erythroid progenitors derived from wild-type embryos compared with PU.1 low embryos for genes bound by PU.1 in MEL (left) or ES-EP (right) are plotted as a function of the number of reads associated with the peak(s) corresponding to each gene. The positions of the values for Klf1, EpoR, Gfi1b, Myb, Fli1, and Sfpi1 in the plots are labeled.CC BY · PubMed Central
Figure 4 PU.1 regulates genes involved in controlling erythroid differentiation. (A) and (B) Signal tracks of PU.1 ChIP-Seq data from MEL cells (blue) and ES-EP (red) in the vicinity of the genes depicted schematically (black) using IGB. Myb, Fli1, Gfi1b, and EpoR are transcribed from the negative strand (right to left), whereas Sfpi1 (PU.1) and Klf1 are expressed in the sense direction (left to right). Input DNA controls are also shown for both cell types. (C) and (D) qChIP validations of PU.1 occupancy at the regions highlighted in yellow in (A) and (B). qChIP was performed as described in Materials and Methods with chromatin from MEL cells (left) and ES-EP (right) with primers described in Table S2. A HA antibody was used as an isotype control. Standard deviations were calculated from triplicate PCR reactions. Similar results were obtained with at least two independent chromatin preparations.
Figure 4 PU.1 regulates genes involved in controlling erythroid differentiation. (A) and (B) Signal tracks of PU.1 ChIP-Seq data from MEL cells (blue) and ES-EP (red) in the vicinity of the genes depicted schematically (black) using IGB. Myb, Fli1, Gfi1b, and EpoR are transcribed from the negative strand (right to left), whereas Sfpi1 (PU.1) and Klf1 are expressed in the sense direction (left to right). Input DNA controls are also shown for both cell types. (C) and (D) qChIP validations of PU.1 occupancy at the regions highlighted in yellow in (A) and (B). qChIP was performed as described in Materials and Methods with chromatin from MEL cells (left) and ES-EP (right) with primers described in Table S2. A HA antibody was used as an isotype control. Standard deviations were calculated from triplicate PCR reactions. Similar results were obtained with at least two independent chromatin preparations.CC BY · PubMed Central
Figure 5 PU.1 regulates many genes in the PI3K/Akt and ERK/MAPK signaling pathways. (A) and (B) IPA analysis was performed as described in Materials and Methods on PU.1 target genes in both ES-EP and MEL cells. The PI3K/Akt and ERK/MAPK signaling pathways were identified as being significantly over-represented among those genes. The left part of each panel depicts all of the components of the indicated IPA pathway. Components denoted with a filled yellow circle indicate that the gene for that component is associated with a PU.1 ChIP-Seq peak in both ES-EP and MEL cells. To the right of each pathway is shown the results of gene expression analysis of the indicated genes in early erythroid progenitors derived from wild-type embryos relative to PU.1 low embryos.
Figure 5 PU.1 regulates many genes in the PI3K/Akt and ERK/MAPK signaling pathways. (A) and (B) IPA analysis was performed as described in Materials and Methods on PU.1 target genes in both ES-EP and MEL cells. The PI3K/Akt and ERK/MAPK signaling pathways were identified as being significantly over-represented among those genes. The left part of each panel depicts all of the components of the indicated IPA pathway. Components denoted with a filled yellow circle indicate that the gene for that component is associated with a PU.1 ChIP-Seq peak in both ES-EP and MEL cells. To the right of each pathway is shown the results of gene expression analysis of the indicated genes in early erythroid progenitors derived from wild-type embryos relative to PU.1 low embryos.CC BY · PubMed Central
Figure 6 Reduction in early erythroid progenitors in PU.1 depleted embryos. (A) Fetal livers were isolated from E13.5–14 day old embryos from WT (URE+/+), heterozygous (URE+/−), and homozygous (URE−/−) animals. Distinct erythroid populations were identified by staining with TER119 and CD71, with representative stainings shown. The percent of R1 cells present from two animals from each genotype was averaged and is displayed as a bar graph. * t-test<0.05, ** t-test<0.01 compared to URE+/+. (B) Apoptosis was analyzed by Annexin-V staining of R1 cells. The percentage of Annexin-V positive cells is shown as an average of two animals from each genotype. *t-test<0.05 compared to URE+/+.
Figure 6 Reduction in early erythroid progenitors in PU.1 depleted embryos. (A) Fetal livers were isolated from E13.5–14 day old embryos from WT (URE+/+), heterozygous (URE+/−), and homozygous (URE−/−) animals. Distinct erythroid populations were identified by staining with TER119 and CD71, with representative stainings shown. The percent of R1 cells present from two animals from each genotype was averaged and is displayed as a bar graph. * t-test<0.05, ** t-test<0.01 compared to URE+/+. (B) Apoptosis was analyzed by Annexin-V staining of R1 cells. The percentage of Annexin-V positive cells is shown as an average of two animals from each genotype. *t-test<0.05 compared to URE+/+.CC BY · PubMed Central
Figure 7 PU.1 occupies many of the same gene targets in myeloid and erythroid cells, and PU.1-dependent gene regulation is similar in HSC, myeloid, and erythroid cells. (A) qChIP was performed for PU.1 as described in Materials and Methods with chromatin from 32D cells using primers described in Table S2. An HA antibody was used as an isotype control. The same primers were used to show that PU.1 binds close to these genes in MEL cells and ES-EP (Figure S5). The myogenin gene serves as a negative control. Standard deviations were calculated from triplicate PCR reactions. Similar results were obtained with at least two independent chromatin preparations. (B) Expression data from PU.1−/− cells stimulated to differentiate into macrophages by the restoration of PU.1 [49] and HSC from PU.1 knockdown mice [33] were used to compare with PU.1 dependent gene regulation in early erythroid progenitors from PU.1 knockdown mice. Of the PU.1 bound genes in MEL and ES-EP that displayed a ≥1.5-fold change in expression, 308 were upregulated and 209 were downregulated. 162 and 265 of these PU.1 dependent genes were annotated in the other 2 datasets. Venn diagrams display the comparisons between the three datasets of these upregulated genes (left) and downregulated genes (right).
Figure 7 PU.1 occupies many of the same gene targets in myeloid and erythroid cells, and PU.1-dependent gene regulation is similar in HSC, myeloid, and erythroid cells. (A) qChIP was performed for PU.1 as described in Materials and Methods with chromatin from 32D cells using primers described in Table S2. An HA antibody was used as an isotype control. The same primers were used to show that PU.1 binds close to these genes in MEL cells and ES-EP (Figure S5). The myogenin gene serves as a negative control. Standard deviations were calculated from triplicate PCR reactions. Similar results were obtained with at least two independent chromatin preparations. (B) Expression data from PU.1−/− cells stimulated to differentiate into macrophages by the restoration of PU.1 [49] and HSC from PU.1 knockdown mice [33] were used to compare with PU.1 dependent gene regulation in early erythroid progenitors from PU.1 knockdown mice. Of the PU.1 bound genes in MEL and ES-EP that displayed a ≥1.5-fold change in expression, 308 were upregulated and 209 were downregulated. 162 and 265 of these PU.1 dependent genes were annotated in the other 2 datasets. Venn diagrams display the comparisons between the three datasets of these upregulated genes (left) and downregulated genes (right).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 75 references

Cited by

See all 53

Metadata

Authors
Wontakal, S. N., Guo, X., Will, B., Shi, M., Raha, D., Mahajan, M. C., Weissman, S., Snyder, M., Steidl, U., Zheng, D., & Skoultchi, A. I.
Affiliations
  • Albert Einstein College of Medicine (US)
  • Yale University (US)
Corresponding author
  • Zheng, Deyou
  • Skoultchi, Arthur I.
Venue
PLoS Genetics
Published
2011-06-09
Volume
7
Issue
6
Pages
e1001392
ISSN
  • 1553-7390 (ISSN-L)
  • 1553-7404
OpenAlex
W1975400920
Cited by
53
References
75
Citations by year
2026: 1 · 2025: 2 · 2024: 5 · 2023: 3 · 2022: 2 · 2020: 1 · 2019: 3 · 2017: 2 · 2016: 1 · 2015: 5 · 2014: 2 · 2013: 14 · 2012: 12
FWCI
6.13
Type
journal article
Language
en
Open access
Locations
  • PLoS Genetics (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
Funders
  • Yeshiva University
  • National Institutes of Health
  • Albert Einstein College of Medicine, Yeshiva University
  • National Heart, Lung, and Blood Institute (R01HL078381)
  • National Eye Institute (EY012200, R01EY012200)
  • National Cancer Institute (2P30-CA13330, R01CA166429, HL078381/CA154239, R00CA131503, P30CA013330)
  • National Institute of General Medical Sciences (5T32GM07288, T32GM007288)
Topics
  • Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
Keywords
PU.1, erythroid progenitor cells, erythroid differentiation, GATA-1, hematopoietic transcription factors, gene regulatory networks, myeloid development, B cell development
MeSH terms
Proto-Oncogene Protein Spi-1, Animals, Cell Differentiation, Cell Line, Proto-Oncogene Proteins, Transcription, Genetic, Trans-Activators, Erythroid Precursor Cells, Cell Lineage, Chromatin Immunoprecipitation, Mice, Gene Regulatory Networks

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Large Gene Network in Immature Erythroid Cells Is Controlled by the Myeloid and B Cell Transcriptional Regulator PU.1. https://app.cochat.ai/papers/10.1371/journal.pgen.1001392
The paper
Wontakal, S. N., Guo, X., Will, B., Shi, M., Raha, D., Mahajan, M. C., Weissman, S., Snyder, M., Steidl, U., Zheng, D., & Skoultchi, A. I. (2011). A Large Gene Network in Immature Erythroid Cells Is Controlled by the Myeloid and B Cell Transcriptional Regulator PU.1. PLoS Genetics. https://doi.org/10.1371/journal.pgen.1001392

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.